Cancer patient treatment is largely divided into surgery, radiotherapy and chemotherapy. The Dept. of Hematology and Oncology mainly handles chemotherapy. To maximize the antitumor effect and to minimize the adverse effects of chemotherapy, it is important to select an appropriate drug and the respective dose according to the patient’s physical condition, cancer type and the purpose of treatment.

The Dept. of Hematology and Oncology treats solid cancers, such as lung cancer, gastric cancer, colorectal cancer and breast cancer, and hematomas, such as acute adult leukemia, chronic leukemia and multiple myeloma, mainly through chemotherapy. Together with target therapy, which has come into the limelight recently as an epochal cancer treatment method, the Dept. of Hematology and Oncology administers treatment customized for individual patients. Specialists in various cancers and the associated chemotherapies in each sub-department manage anticancer drug administration to patients and the related side effects.

In addition to hematoma, the Dept. of Hematology and Oncology diagnoses and treats hematodyscrasia, such as anemia, leukopenia and thrombocytopenia.

• Target Diseases
  • Various solid cancers (lung cancer, gastric cancer, colorectal cancer, breast cancer, head and neck cancer, renal cancer)
  • Various hematomas (leukemia, multiple myeloma, myeloproliferative disorders, lymphoma)
  • Other hematodyscrasia (anemia, idiopathic thrombocytopenia, eosinophilia)